연구동향 분석

The Cumulative Effect of Antipsychotic Usage on Mortality in Schizophrenia: A Nationwide Population-based Cohort Study in Korea

Gyurin Kim Soo Jung Rim Minkyung Jo Min Geu Lee Se Jin Park Subin Park 2022년

논문상세정보
인용/피인용
' The Cumulative Effect of Antipsychotic Usage on Mortality in Schizophrenia: A Nationwide Population-based Cohort Study in Korea' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Mortality
  • antipsychotics
  • schizophrenia
  • south korea
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
2,033 0

0.0%

' The Cumulative Effect of Antipsychotic Usage on Mortality in Schizophrenia: A Nationwide Population-based Cohort Study in Korea' 의 참고문헌

  • Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels : results from the Global Burden of Disease Study 2017
    He H [2020]
  • Premature mortality among adults with schizophrenia in the United States
    Olfson M [2015]
  • Premature death in schizophrenia : bridging the gap
    Galletly CA [2017]
  • New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality
  • Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia : an observational follow-up study
    Tiihonen J [2016]
  • Influence of antipsychotics on mortality in schizophrenia : systematic review
    Weinmann S [2009]
  • Higher mortality and years of potential life lost of suicide in patients with schizophrenia
    Ko YS [2018]
  • Guideline-concordant antipsychotic use and mortality in schizophrenia
    Cullen BA [2013]
  • Global economic burden of schizophrenia : a systematic review
    Chong HY [2016]
  • Excess early mortality in schizophrenia
    Laursen TM [2014]
  • Diagnostic and statistical manual of mental disorders (DSM-5®)
  • Decreased cardiovascular death in schizophrenia patients treated with antipsychotics : a Korean national cohort study
    Oh J [2021]
  • Comparison of long-acting injectable antipsychotics with oral antipsychotics and suicide and all-cause mortality in patients with newly diagnosed schizophrenia
    Huang CY [2021]
  • Comorbidities and mortality in persons with schizophrenia : a Swedish national cohort study
    Crump C [2013]
  • Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 years
  • Causes of the excess mortality of schizophrenia
    Brown S [2000]
  • Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
    Lahti M [2012]
  • Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association(EPA), supported by the European Association for the Study of Diabetes(EASD)and the European Society of Cardiology(ESC)
    De Hert M [2009]
  • Antipsychotics and mortality in a nationwide cohort of 29, 823 patients with schizophrenia
    Taipale H [2018]
  • Antipsychotic treatment and mortality in schizophrenia
  • Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia : a population-based nested case-control study
    Baandrup L [2010]
  • An evaluation of variation in published estimates of schizophrenia prevalence from 1990-2013 : a systematic literature review
    Simeone JC [2015]
  • A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia
    Tiihonen J [2011]
  • 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62, 250 patients with schizophrenia(FIN20)
    Taipale H [2020]
  • 11-year follow-up of mortality in patients with schizophrenia : a population-based cohort study(FIN11study)
    Tiihonen J [2009]